China Human Microbiome Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Human Microbiome market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Human Microbiome market. Detailed analysis of key players, along with key growth strategies adopted by Human Microbiome industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Second Genome

    • Seres Therapeutics

    • Miomics

    • Osel

    • Symbiotix Biotherapies

    • Enterome BioScience

    • Metabiomics

    • MicroBiome Therapeutics LLC

    • ActoGeniX

    • Symberix

    • AvidBiotics

    • Ritter Pharmaceuticals

    • Metabogen

    • Enterologics

    • Vedanta

    • Rebiotix

    • 4D Pharma Research Ltd

    By Type:

    • Gastrointestinal Tract Human Micobiome

    • Urogenital Tract Human Micobiome

    • Others

    By End-User:

    • Treatment

    • Diagnosis

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Microbiome Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Human Microbiome Market Size and Growth Rate of Gastrointestinal Tract Human Micobiome from 2016 to 2027

    • 1.3.2 China Human Microbiome Market Size and Growth Rate of Urogenital Tract Human Micobiome from 2016 to 2027

    • 1.3.3 China Human Microbiome Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Human Microbiome Market Size and Growth Rate of Treatment from 2016 to 2027

    • 1.4.2 China Human Microbiome Market Size and Growth Rate of Diagnosis from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Human Microbiome Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Microbiome by Major Types

    • 3.4.1 Market Size and Growth Rate of Gastrointestinal Tract Human Micobiome

    • 3.4.2 Market Size and Growth Rate of Urogenital Tract Human Micobiome

    • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Human Microbiome Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Microbiome by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Human Microbiome in Treatment

    • 4.4.2 Market Size and Growth Rate of Human Microbiome in Diagnosis

    5 Market Analysis by Regions

    • 5.1 China Human Microbiome Production Analysis by Regions

    • 5.2 China Human Microbiome Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Human Microbiome Landscape Analysis

    • 6.1 North China Human Microbiome Landscape Analysis by Major Types

    • 6.2 North China Human Microbiome Landscape Analysis by Major End-Users

    7 Central China Human Microbiome Landscape Analysis

    • 7.1 Central China Human Microbiome Landscape Analysis by Major Types

    • 7.2 Central China Human Microbiome Landscape Analysis by Major End-Users

    8 South China Human Microbiome Landscape Analysis

    • 8.1 South China Human Microbiome Landscape Analysis by Major Types

    • 8.2 South China Human Microbiome Landscape Analysis by Major End-Users

    9 East China Human Microbiome Landscape Analysis

    • 9.1 East China Human Microbiome Landscape Analysis by Major Types

    • 9.2 East China Human Microbiome Landscape Analysis by Major End-Users

    10 Northeast China Human Microbiome Landscape Analysis

    • 10.1 Northeast China Human Microbiome Landscape Analysis by Major Types

    • 10.2 Northeast China Human Microbiome Landscape Analysis by Major End-Users

    11 Southwest China Human Microbiome Landscape Analysis

    • 11.1 Southwest China Human Microbiome Landscape Analysis by Major Types

    • 11.2 Southwest China Human Microbiome Landscape Analysis by Major End-Users

    12 Northwest China Human Microbiome Landscape Analysis

    • 12.1 Northwest China Human Microbiome Landscape Analysis by Major Types

    • 12.2 Northwest China Human Microbiome Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Second Genome

      • 13.1.1 Second Genome Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Seres Therapeutics

      • 13.2.1 Seres Therapeutics Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Miomics

      • 13.3.1 Miomics Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Osel

      • 13.4.1 Osel Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Symbiotix Biotherapies

      • 13.5.1 Symbiotix Biotherapies Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Enterome BioScience

      • 13.6.1 Enterome BioScience Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Metabiomics

      • 13.7.1 Metabiomics Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 MicroBiome Therapeutics LLC

      • 13.8.1 MicroBiome Therapeutics LLC Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 ActoGeniX

      • 13.9.1 ActoGeniX Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Symberix

      • 13.10.1 Symberix Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 AvidBiotics

      • 13.11.1 AvidBiotics Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Ritter Pharmaceuticals

      • 13.12.1 Ritter Pharmaceuticals Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Metabogen

      • 13.13.1 Metabogen Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Enterologics

      • 13.14.1 Enterologics Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Vedanta

      • 13.15.1 Vedanta Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Rebiotix

      • 13.16.1 Rebiotix Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 4D Pharma Research Ltd

      • 13.17.1 4D Pharma Research Ltd Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Human Microbiome Market Size and Growth Rate of Gastrointestinal Tract Human Micobiome from 2016 to 2027

    • Figure China Human Microbiome Market Size and Growth Rate of Urogenital Tract Human Micobiome from 2016 to 2027

    • Figure China Human Microbiome Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Human Microbiome Market Size and Growth Rate of Treatment from 2016 to 2027

    • Figure China Human Microbiome Market Size and Growth Rate of Diagnosis from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Human Microbiome Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Human Microbiome Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Human Microbiome

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Microbiome by Different Types from 2016 to 2027

    • Table Consumption Share of Human Microbiome by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Gastrointestinal Tract Human Micobiome

    • Figure Market Size and Growth Rate of Urogenital Tract Human Micobiome

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Human Microbiome by Different End-Users from 2016 to 2027

    • Table Consumption Share of Human Microbiome by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Treatment

    • Figure Market Size and Growth Rate of Diagnosis

    • Table China Human Microbiome Production by Regions

    • Table China Human Microbiome Production Share by Regions

    • Figure China Human Microbiome Production Share by Regions in 2016

    • Figure China Human Microbiome Production Share by Regions in 2021

    • Figure China Human Microbiome Production Share by Regions in 2027

    • Table China Human Microbiome Consumption by Regions

    • Table China Human Microbiome Consumption Share by Regions

    • Figure China Human Microbiome Consumption Share by Regions in 2016

    • Figure China Human Microbiome Consumption Share by Regions in 2021

    • Figure China Human Microbiome Consumption Share by Regions in 2027

    • Table North China Human Microbiome Consumption by Types from 2016 to 2027

    • Table North China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure North China Human Microbiome Consumption Share by Types in 2016

    • Figure North China Human Microbiome Consumption Share by Types in 2021

    • Figure North China Human Microbiome Consumption Share by Types in 2027

    • Table North China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table North China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure North China Human Microbiome Consumption Share by End-Users in 2016

    • Figure North China Human Microbiome Consumption Share by End-Users in 2021

    • Figure North China Human Microbiome Consumption Share by End-Users in 2027

    • Table Central China Human Microbiome Consumption by Types from 2016 to 2027

    • Table Central China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure Central China Human Microbiome Consumption Share by Types in 2016

    • Figure Central China Human Microbiome Consumption Share by Types in 2021

    • Figure Central China Human Microbiome Consumption Share by Types in 2027

    • Table Central China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table Central China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Human Microbiome Consumption Share by End-Users in 2016

    • Figure Central China Human Microbiome Consumption Share by End-Users in 2021

    • Figure Central China Human Microbiome Consumption Share by End-Users in 2027

    • Table South China Human Microbiome Consumption by Types from 2016 to 2027

    • Table South China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure South China Human Microbiome Consumption Share by Types in 2016

    • Figure South China Human Microbiome Consumption Share by Types in 2021

    • Figure South China Human Microbiome Consumption Share by Types in 2027

    • Table South China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table South China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure South China Human Microbiome Consumption Share by End-Users in 2016

    • Figure South China Human Microbiome Consumption Share by End-Users in 2021

    • Figure South China Human Microbiome Consumption Share by End-Users in 2027

    • Table East China Human Microbiome Consumption by Types from 2016 to 2027

    • Table East China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure East China Human Microbiome Consumption Share by Types in 2016

    • Figure East China Human Microbiome Consumption Share by Types in 2021

    • Figure East China Human Microbiome Consumption Share by Types in 2027

    • Table East China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table East China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure East China Human Microbiome Consumption Share by End-Users in 2016

    • Figure East China Human Microbiome Consumption Share by End-Users in 2021

    • Figure East China Human Microbiome Consumption Share by End-Users in 2027

    • Table Northeast China Human Microbiome Consumption by Types from 2016 to 2027

    • Table Northeast China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Human Microbiome Consumption Share by Types in 2016

    • Figure Northeast China Human Microbiome Consumption Share by Types in 2021

    • Figure Northeast China Human Microbiome Consumption Share by Types in 2027

    • Table Northeast China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table Northeast China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Human Microbiome Consumption Share by End-Users in 2016

    • Figure Northeast China Human Microbiome Consumption Share by End-Users in 2021

    • Figure Northeast China Human Microbiome Consumption Share by End-Users in 2027

    • Table Southwest China Human Microbiome Consumption by Types from 2016 to 2027

    • Table Southwest China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Human Microbiome Consumption Share by Types in 2016

    • Figure Southwest China Human Microbiome Consumption Share by Types in 2021

    • Figure Southwest China Human Microbiome Consumption Share by Types in 2027

    • Table Southwest China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table Southwest China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Human Microbiome Consumption Share by End-Users in 2016

    • Figure Southwest China Human Microbiome Consumption Share by End-Users in 2021

    • Figure Southwest China Human Microbiome Consumption Share by End-Users in 2027

    • Table Northwest China Human Microbiome Consumption by Types from 2016 to 2027

    • Table Northwest China Human Microbiome Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Human Microbiome Consumption Share by Types in 2016

    • Figure Northwest China Human Microbiome Consumption Share by Types in 2021

    • Figure Northwest China Human Microbiome Consumption Share by Types in 2027

    • Table Northwest China Human Microbiome Consumption by End-Users from 2016 to 2027

    • Table Northwest China Human Microbiome Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Human Microbiome Consumption Share by End-Users in 2016

    • Figure Northwest China Human Microbiome Consumption Share by End-Users in 2021

    • Figure Northwest China Human Microbiome Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Second Genome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Second Genome

    • Figure Sales and Growth Rate Analysis of Second Genome

    • Figure Revenue and Market Share Analysis of Second Genome

    • Table Product and Service Introduction of Second Genome

    • Table Company Profile and Development Status of Seres Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seres Therapeutics

    • Figure Sales and Growth Rate Analysis of Seres Therapeutics

    • Figure Revenue and Market Share Analysis of Seres Therapeutics

    • Table Product and Service Introduction of Seres Therapeutics

    • Table Company Profile and Development Status of Miomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Miomics

    • Figure Sales and Growth Rate Analysis of Miomics

    • Figure Revenue and Market Share Analysis of Miomics

    • Table Product and Service Introduction of Miomics

    • Table Company Profile and Development Status of Osel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osel

    • Figure Sales and Growth Rate Analysis of Osel

    • Figure Revenue and Market Share Analysis of Osel

    • Table Product and Service Introduction of Osel

    • Table Company Profile and Development Status of Symbiotix Biotherapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Symbiotix Biotherapies

    • Figure Sales and Growth Rate Analysis of Symbiotix Biotherapies

    • Figure Revenue and Market Share Analysis of Symbiotix Biotherapies

    • Table Product and Service Introduction of Symbiotix Biotherapies

    • Table Company Profile and Development Status of Enterome BioScience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enterome BioScience

    • Figure Sales and Growth Rate Analysis of Enterome BioScience

    • Figure Revenue and Market Share Analysis of Enterome BioScience

    • Table Product and Service Introduction of Enterome BioScience

    • Table Company Profile and Development Status of Metabiomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabiomics

    • Figure Sales and Growth Rate Analysis of Metabiomics

    • Figure Revenue and Market Share Analysis of Metabiomics

    • Table Product and Service Introduction of Metabiomics

    • Table Company Profile and Development Status of MicroBiome Therapeutics LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroBiome Therapeutics LLC

    • Figure Sales and Growth Rate Analysis of MicroBiome Therapeutics LLC

    • Figure Revenue and Market Share Analysis of MicroBiome Therapeutics LLC

    • Table Product and Service Introduction of MicroBiome Therapeutics LLC

    • Table Company Profile and Development Status of ActoGeniX

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ActoGeniX

    • Figure Sales and Growth Rate Analysis of ActoGeniX

    • Figure Revenue and Market Share Analysis of ActoGeniX

    • Table Product and Service Introduction of ActoGeniX

    • Table Company Profile and Development Status of Symberix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Symberix

    • Figure Sales and Growth Rate Analysis of Symberix

    • Figure Revenue and Market Share Analysis of Symberix

    • Table Product and Service Introduction of Symberix

    • Table Company Profile and Development Status of AvidBiotics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AvidBiotics

    • Figure Sales and Growth Rate Analysis of AvidBiotics

    • Figure Revenue and Market Share Analysis of AvidBiotics

    • Table Product and Service Introduction of AvidBiotics

    • Table Company Profile and Development Status of Ritter Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ritter Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ritter Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ritter Pharmaceuticals

    • Table Product and Service Introduction of Ritter Pharmaceuticals

    • Table Company Profile and Development Status of Metabogen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Metabogen

    • Figure Sales and Growth Rate Analysis of Metabogen

    • Figure Revenue and Market Share Analysis of Metabogen

    • Table Product and Service Introduction of Metabogen

    • Table Company Profile and Development Status of Enterologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enterologics

    • Figure Sales and Growth Rate Analysis of Enterologics

    • Figure Revenue and Market Share Analysis of Enterologics

    • Table Product and Service Introduction of Enterologics

    • Table Company Profile and Development Status of Vedanta

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vedanta

    • Figure Sales and Growth Rate Analysis of Vedanta

    • Figure Revenue and Market Share Analysis of Vedanta

    • Table Product and Service Introduction of Vedanta

    • Table Company Profile and Development Status of Rebiotix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rebiotix

    • Figure Sales and Growth Rate Analysis of Rebiotix

    • Figure Revenue and Market Share Analysis of Rebiotix

    • Table Product and Service Introduction of Rebiotix

    • Table Company Profile and Development Status of 4D Pharma Research Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 4D Pharma Research Ltd

    • Figure Sales and Growth Rate Analysis of 4D Pharma Research Ltd

    • Figure Revenue and Market Share Analysis of 4D Pharma Research Ltd

    • Table Product and Service Introduction of 4D Pharma Research Ltd


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.